Adams Brian

Insider profile

Performance

Overall performance
4.3

Performance over holding periods
4.3
30 days 90 days 120 days
Average return 21% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
30 0% Buy
34 71% Buy
47 69% Buy
Adams Brian's trades of Kymera Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-04 2026-09-04 S Sale
93,614 -6.2%
462.51
US$3,736,334
93,614 -6.2% 462.51 US$3,736,334
2026-09-04 2026-09-04 S Sale
580 -31.2%
14.14
US$3,586,111
580 -31.2% 14.14 US$3,586,111
2026-09-04 2026-09-04 S Sale
6,947 -36.5%
477.86
US$203,684
6,947 -36.5% 477.86 US$203,684
2026-09-04 2026-09-04 PrS Proposed sale
6,371
117.28
US$747,191
6,371 117.28 US$747,191
2025-04-30 2025-04-30 S Sale
12,943 -3.2%
3.00
US$38,829
12,943 -3.2% 3.00 US$38,829
2025-04-30 2025-04-28 S Sale
1,644 -0.4%
3.17
US$5,211
1,644 -0.4% 3.17 US$5,211
2025-03-31 2025-03-27 S Sale
298 -0.1%
2.84
US$846
298 -0.1% 2.84 US$846
2025-01-30 2025-01-30 S Sale
20,791 -4.9%
4.42
US$91,896
20,791 -4.9% 4.42 US$91,896
2025-01-30 2025-01-28 S Sale
33,688 -10.5%
4.63
US$155,975
33,688 -10.5% 4.63 US$155,975
2024-12-31 2024-12-27 S Sale
299 -0.1%
4.38
US$1,310
299 -0.1% 4.38 US$1,310
2024-10-30 2024-10-28 S Sale
1,632 -0.5%
6.06
US$9,890
1,632 -0.5% 6.06 US$9,890
2024-10-01 2024-09-27 S Sale
295 -0.1%
7.51
US$2,215
295 -0.1% 7.51 US$2,215
2024-07-31 2024-07-29 S Sale
1,638 -0.5%
8.85
US$14,496
1,638 -0.5% 8.85 US$14,496
2024-07-01 2024-06-27 S Sale
295 -0.1%
6.26
US$1,847
295 -0.1% 6.26 US$1,847
2024-04-29 2024-04-29 S Sale
1,623 -0.5%
6.38
US$10,355
1,623 -0.5% 6.38 US$10,355
2024-04-29 2024-04-29 S Sale
1,623 -0.5%
6.38
US$10,355
1,623 -0.5% 6.38 US$10,355
2024-03-29 2024-03-27 S Sale
348 -0.1%
7.70
US$2,680
348 -0.1% 7.70 US$2,680
2024-01-31 2024-01-29 S Sale
1,929 -0.6%
9.64
US$18,596
1,929 -0.6% 9.64 US$18,596
2023-12-29 2023-12-27 S Sale
294 -0.2%
11.51
US$3,384
294 -0.2% 11.51 US$3,384
2023-11-01 2023-10-30 S Sale
1,632 -1.2%
6.03
US$9,841
1,632 -1.2% 6.03 US$9,841
2023-09-29 2023-09-27 S Sale
294 -0.2%
8.38
US$2,464
294 -0.2% 8.38 US$2,464
2023-07-31 2023-07-28 S Sale
1,628 -1.2%
11.80
US$19,210
1,628 -1.2% 11.80 US$19,210
2023-06-28 2023-06-27 S Sale
294 -0.2%
12.12
US$3,563
294 -0.2% 12.12 US$3,563
2023-05-01 2023-04-28 S Sale
863 -0.6%
11.16
US$9,631
863 -0.6% 11.16 US$9,631
2023-03-28 2023-03-27 S Sale
347 -0.3%
15.36
US$5,330
347 -0.3% 15.36 US$5,330
2023-01-31 2023-01-30 S Sale
864 -0.6%
21.56
US$18,628
864 -0.6% 21.56 US$18,628
2023-01-13 2023-01-12 PlS Planned sale
9,994 -16.2%
20.00
US$199,880
9,994 -16.2% 20.00 US$199,880
2022-12-28 2022-12-27 S Sale
295 -0.5%
14.49
US$4,275
295 -0.5% 14.49 US$4,275
2022-11-01 2022-10-28 S Sale
728 -1.2%
21.54
US$15,681
728 -1.2% 21.54 US$15,681
2022-09-29 2022-09-27 S Sale
294 -0.5%
22.73
US$6,683
294 -0.5% 22.73 US$6,683
2022-07-29 2022-07-28 S Sale
734 -1.2%
21.27
US$15,612
734 -1.2% 21.27 US$15,612
2022-06-28 2022-06-27 S Sale
300 -0.5%
20.31
US$6,093
300 -0.5% 20.31 US$6,093
2022-05-02 2022-04-28 S Sale
708 -1.1%
25.57
US$18,104
708 -1.1% 25.57 US$18,104
2021-11-16 2021-11-15 PlS Planned sale
6,500 -20.5%
35.42
US$230,230
6,500 -20.5% 35.42 US$230,230
2021-09-27 2021-09-27 S Sale
293 -1.1%
36.87
US$10,803
293 -1.1% 36.87 US$10,803
2021-09-13 2021-09-13 PlS Planned sale
6,500 -20.3%
35.02
US$227,630
6,500 -20.3% 35.02 US$227,630
2021-06-09 2021-06-07 PlS Planned sale
6,500 -20.1%
35.00
US$227,500
6,500 -20.1% 35.00 US$227,500
2021-04-28 2021-04-26 PlS Planned sale
6,500 -20.1%
35.00
US$227,500
6,500 -20.1% 35.00 US$227,500
2021-01-29 2021-01-28 S Sale
5,000 -33.3%
55.05
US$275,250
5,000 -33.3% 55.05 US$275,250
2020-07-21 2020-07-20 B Purchase
10,000 +inf%
20.00
US$200,000
10,000 +inf% 20.00 US$200,000